CANCER OF UNKNOWN PRIMARY
Clinical trials for CANCER OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new CANCER OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for CANCER OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: CANCER OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 10:51 UTC
-
Blood test could unlock hidden cancer secrets for patients with unknown primary tumors
Knowledge-focused Recruiting nowThis study looks at using a blood test (liquid biopsy) to analyze DNA from cancer cells in people with Cancer of Unknown Primary (CUP), where the original cancer site is unknown. The goal is to find genetic changes that could guide personalized treatment or clinical trial options…
Matched conditions: CANCER OF UNKNOWN PRIMARY
Sponsor: The Christie NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 17, 2026 10:51 UTC